New Division At Danish Medicines Agency To Put Greater Focus On Benefit-Risk Issues
Executive Summary
Major organizational changes are in store for the Danish Medicines Agency in the New Year that will aim to modernize its processes and functioning.
You may also be interested in...
Danish Pharma Hopes Stand-alone Medicines Agency Will Speed Up Drug Reviews
Pharma group hopes DMA will clear up drug review backlog once it is separated from larger health authority.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.